Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections — Christina Schmitt (2023) | RDL Network
Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections
Article 2023 en
Authors
CS
Christina Schmitt
EH
Esmée P. Hoefsmit
TF
Thomas Fangmeier
Abstract
1 min read
Previous viral, bacterial and protozoal neurotropic infections appear not to be associated with the development of neurological irAEs in melanoma patients who underwent therapy with ICI across 3 countries. Further efforts are needed to unravel the factors underlying neurological irAEs in order to identify risk factors for these toxicities, especially with the increasing use of ICI in earlier stage disease.
Rebecca Simpson, Erin R. Shanahan, Marcel Batten, Inês Pires da Silva, Irene L. M. Reijers, Judith M. Versluis, Alexander M. Menzies, Maria Gonzalez, Umaimainthan Palendira, Andrew Holmes, James S. Wilmott, Christian U. Blank, Richard A Scolyer, Georgina V. Long
Jess Louise Smith, Alexander M. Menzies, Justine V. Cohen, Margarida Mut Lioret, Alpaslan Özgün, Lavinia Spain, John Park, Douglas B. Johnson, Jennifer L. McQuade, Sophie Feng, Shahneen Sandhu, Victoria Atkinson, Katy K. Tsai, Georgina V. Long, James Larkin, Zeynep Eroglu, Ryan J. Sullivan, Andrew Henderson, Matteo S. Carlino
Linda Wu, John M. Wentworth, Christopher Liddle, Nicole Fewings, Matteo S. Carlino, David A. Brown, Roderick Clifton‐Bligh, Georgina V. Long, Richard A Scolyer, Nicholas Norris, Sarah C. Sasson, Venessa Tsang, Alexander M. Menzies, Jenny E. Gunton
Discussion(0)
No comments yet. Be the first to comment.